Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 EP471 | DOI: 10.1530/endoabs.37.EP471

ECE2015 Eposter Presentations Diabetes (complications & therapy) (143 abstracts)

Long-term tele-monitoring of patients with type 2 diabetes mellitus: ancillary analysis of the results of the Greek pilot of the renewing health multicentre randomised control trial

George E Dafoulas 1, , Afentoula Mavrodi 3 , Charalampos Giannakakos 4 , Paraskevi Gkiata 5 , Kyriaki Theodorou 1 , Vasilios Aletras 3 , Panagiotis Stafylas 6 , Georgios Koukoulis 1, & Alexandra Bargiota 1,


1Faculty of Medicine, University of Thessaly, Larisa, Greece; 2E-Trikala Telehealth Center, Municipality of Trikala, Trikala, Greece; 3Department of Business Administration, University of Macedonia, Thessaloniki, Greece; 45th Regional Health Authority of Thessaly and Sterea, Larisa, Greece; 5Telehealth Center, Intermunicipal Digital Community of Central Greece, Trikala, Greece; 6Health Information Management, Brussels, Belgium; 7Department of Endocrinology and Metabolic Diseases, Regional University Hospital, Larisa, Greece.


Introduction: To evaluate the impact of a long-term telemonitoring programme for patients with type 2 diabetes mellitus (DMT2) on glycaemic control and lipid disorders.

Methods/design: In the Greek pilot of a prospective, randomised, single-blinded, multicentre study 154 patients with DMT2, HbA1c >53 mmol/mol (7.0% according to NGSP) and capable of using the telemonitoring device, were studied after randomly assigned in the telemonitoring (IG) (n=74) and the control group (CG) (n=80) and after having signed the informed consent form. In the IG group patients’ blood glucose profiles were collected weekly using a mobile phone health platform, for a period of 1 year. Allocated health professionals provided via phone the appropriate counselling on lifestyle and medication changes whenever required. Patients in (CG) group received usual care with face-to-face consultations. Levels of HbA1c (primary outcome), total cholesterol (TChol), LDL, and triglycerides (Tg) were measured at the beginning and the end of the study.

Results: The table shows the outcome of the variables studied in both groups. A greater reduction in HbA1c was observed in the IG compared to the CG. Linear regression analysis performed proved that no significant contribution to the reduction of HbA1c level could be attributed to patients’ demographics, age (R2=0.099, P=0.103), gender (R2=0.061, P=0.316), level of education (R2=0.034, P=0.572), prior use of computer (R2=0.062, P=0.309), and prior use of mobile phone (R2=0.005, P=0.406).

OutcomeMean difference between groups (95% CI)P value
HbA1c (mmol/mol)−6.13 (−10.45 to −1.81)0.001
TChol (mg/dl)−2.41 (−18.48 to 13.65)0.765
LDL (mg/dl)−6.72 (−16.02 to 2.57)0.155
Tg (mg/dl)−12.90 (−49.97 to 24.17)0.490

Conclusion: In the present study home telemonitoring was proven to be more effective than usual care in improving glycaemic control.

Disclosure: RENEWING HEALTH and UNITED FOR HEALTH are partially funded under the ICT Policy Support Programme (ICT PSP) as part of the Competitiveness and Innovation Framework Programme by the European Community.

Article tools

My recent searches

No recent searches.